Ausgabe 2/2000
Inhalt (11 Artikel)
Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer
Bettina Meiser, Phyllis Butow, Alexandra Barratt, Michael Friedlander, Judy Kirk, Clara Gaff, Eric Haan, K. Aittomäki, Katherine Tucker
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
William H. Goodson III, Dan H. Moore II, Britt-Marie Ljung, Karen Chew, Brian Mayall, Helene S. Smith, Frederic M. Waldman
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
Andrea Michelotti, Marco Venturini, Carmelo Tibaldi, Carmelo Bengala, Luigi Gallo, Flavio Carnino, Lucia Del Mastro, Rita Lionetto, Elda Montanaro, Riccardo Rosso, Pierfranco Conte
Infiltrating dendritic/Langerhans cells in primary breast cancer
Tohru Tsuge, Mitsunori Yamakawa, Masaru Tsukamoto
Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
He Yu, Bhupinder Bharaj, Evyenia J.K. Vassilikos, Maurizia Giai, Eleftherios P. Diamandis
Lipid peroxidation, free radical production and antioxidant status in breast cancer
Gibanananda Ray, Sanjay Batra, Nootan Kumar Shukla, Suryanarayan Deo, Vinod Raina, Seetharaman Ashok, Syed Akhtar Husain
Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy
R.K. Gregory, T.J. Powles, J. Salter, J.C. Chang, S. Ashley, M. Dowsett
Surgical treatment of hepatic metastases from breast cancer
Masataka Yoshimoto, Takashi Tada, Mitsue Saito, Kaoru Takahashi, Masujiro Makita, Yoshihiro Uchida, Fujio Kasumi
Survival and tumor characteristics of German hereditary breast cancer patients
Ute Hamann, Hans-Peter Sinn